Pharmaceuticals
Data From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
- Not intended for US-, Canada- or UK-based media - ASCO Abstract # BAVENCIO® (avelumab): LBA1, 5061; Bintrafusp alfa (bifunctional fusion protein):9558; Tepotinib (MET kinase inhibitor): 9556, 9575. - Late-breaking presentation of Phase III JAVELIN Bladder 100 data for BAVENCIO® showing over...
2020-04-30 20:00
2918
INOVIO Expands Manufacturing of COVID-19 DNA Vaccine INO-4800 With New Funding from CEPI
INOVIO and Richter-Helm BioLogics will expand existing DNA manufacturing agreement to support large-scale manufacturing of INO-4800 INO-4800 Phase 2/3 U.S. clinical trial being prepared to start this summer PLYMOUTH MEETING, Pennsylvania, April 30, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO) today ...
2020-04-30 20:00
3983
CPhI & P-MEC China to host 'Virtual Expo Connect' in June
SHANGHAI, April 30, 2020 /PRNewswire/ -- CPhI and P-MEC China -- co-organized by Informa Markets, CCCMHPIE and Sinoexpo Informa Markets -- will host a special Virtual Expo Connect in June (18-24, 2020). The new online platform is designed to facilitate ongoing and new business connections in an a...
2020-04-30 19:13
4665
WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody™ Platform
SHANGHAI and HOUSTON, April 30, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and Aravive, Inc. (NASDAQ:ARAV), a clinical-stage biopharmaceutical company, today announced a strategic collaboration agreement...
2020-04-30 19:00
1998
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference
- INO-4700 (GLS-5300) DNA vaccine demonstrates 100% binding and 92% neutralizing antibody responses against MERS-CoV - INO-4800 DNA vaccine for COVID-19 currently in Phase 1 trial utilizes identical strategy targeting Spike protein and CELLECTRA intradermal delivery PLYMOUTH MEETING, Pennsylvani...
2020-04-29 04:30
3854
INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June
INO-4800 Phase 2/3 U.S. clinical trial being prepared to start this summer Parallel preclinical challenge studies ongoing PLYMOUTH MEETING, Pa., April 28, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO) today announced that its Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800 is fully enro...
2020-04-28 20:00
3193
PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19
- The objective of the trial is to evaluate the efficacy and safety of plitidepsin in patients with COVID-19 requiring hospital admission - Plitidepsin recently obtained positive results from in vitro studies on the human HCoV-229E coronavirus, carried out at the National Biotechnology Center (C...
2020-04-28 18:57
4154
Insilico Medicine enters into a collaboration research with Astellas Pharma Inc. to apply novel generative artificial intelligence system for a conventionally challenging target family
TSUKUBA, Japan, April 28, 2020 /PRNewswire/ -- Insilico Medicine has announced that it has entered into a research collaboration agreement with Astellas Pharma Inc. to utilize Insilico Medicine's novel generative artificial intelligence technology aimed at accelerating development of candidates a...
2020-04-28 08:46
2358
Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies
The new multiplex cytokine and cytotoxicity assays as a part of the Opto Cell Therapy Development 1.0 workflow will help users of the Berkeley Lights' platform develop cancer immunotherapies faster EMERYVILLE, Calif., April 28, 2020 /PRNewswire/ -- Today, Berkeley Lights, Inc., a leader in Digit...
2020-04-28 00:00
2824
Lianhua Qingwen Approved and Registered by Ministry of Public Health of Ecuador as Natural Medicine
SHIJIAZHUANG, China, April 27, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) has obtained approval from the Ministry of Public Health ofEcuador for the sale and promotion of the Lianhua Qingwen Capsule (Granule) ("Lianhua Qingwen") in the country. The approval officially registers Lianhu...
2020-04-27 20:43
2783
Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19
Enumeration of Circulating Endothelial Cells (CECs) with CELLSEARCH platform may offer a new tool for investigating the role of the damaged endothelium in SARS-CoV-2 infection and clinical manifestation BOLOGNA, Italy, April 27, 2020 /PRNewswire/ -- Menarini Silicon Biosystems, a global leader i...
2020-04-27 20:10
1590
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's International, Phase III Clinical Study
SHANGHAI, April 27, 2020 /PRNewswire/ -- On April 8, 2020, Shanghai Green Valley Pharmaceuticals,China received the formal decision letter from the US Food and Drug Administration (FDA) on the Investigational New Drug (IND) application for the GV-971 international multi-center Phase III clinic...
2020-04-27 16:34
2820
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine
SEATTLE, April 24, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it is partnering with AdaptVac to develop and produce a COVID-19 vaccine. AdaptVac, together with its EU Horizon 2020 sponsored PREVENT-nCoV con...
2020-04-24 14:50
3704
Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC
SUZHOU, China, April 24, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jo...
2020-04-24 07:50
7214
First Patient in Treatment in RhoVac's Clinical Phase IIb Study in Germany
STOCKHOLM, April 24, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on 23rd April 2020, that the first patient in Germany is in treatment in the company's clinical phase IIb study in prostate cancer, a study entitled RhoVac-002 ("BRaVac"). The first patient in Germany is in treatment...
2020-04-24 00:37
2003
Henlius receives EU GMP Certificate for HLX02 (Trastuzumab for Injection)
SHANGHAI, April 23, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's drug substance (DS) line and drug product (DP) line for HLX02 trastuzumab biosimilar have successfully passed the European United (EU) Good Manufacturing Practice (GMP) on-site inspectio...
2020-04-23 22:02
3733
Lianhua Qingwen Listed in the Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme for Laos
SHIJIAZHUANG, China, April 22, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) announced that Lianhua Qingwen capsules (granules) have been added to the "Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme forLaos" (Trial Version II) as the fourth traditional Chinese medicine to tre...
2020-04-23 20:00
6311
Signifier Medical Technologies Collaborates With Global Sleep Experts on Its Innovative Snoozeal(R) Device Clinical Trials
LONDON, April 23, 2020 /PRNewswire/ -- Signifier Medical Technologies, an innovator in the sleep disordered breathing market, today announced that it is partnering with twenty-seven Key Opinion Leaders in Sleep to test and build awareness around its Snoozeal® product in the lead up to its commerc...
2020-04-23 19:00
1883
Luye Pharma Group Selects LifeSphere® Signal and Risk Management to Automate Drug Safety Signal Detection
MIAMI, April 23, 2020 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, today announced Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing, and...
2020-04-23 13:00
2578
New Early Breast Cancer Drug Available Now In Singapore
* NERLYNX® (neratinib) now commercially available in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy * Five-year follow up data show NERLYNX reduces risk of invasive disease recurrence by 42% in women with early-stage, HER2+/HR+ breast cancer and who co...
2020-04-23 12:33
2209
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 287 media titles]
2025-01-14 21:00
Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04VANTAGE FOUNDATION SUPPORTS GRAB INDONESIA IN EMPOWERING WOMEN DRIVER-PARTNER
[Picked up by 280 media titles]
2025-01-09 18:26
Most Read
Hyundai Motor Group Partners with NVIDIA to Accelerate Development of AI Solutions for Future Mobility
2025-01-10 01:00
20545
AIMA Unveils Game-Changing 2025 eBike Lineup at CES: Better Performance, More Freedom
2025-01-09 02:34
6515
RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air
2025-01-11 01:00
5849
Boqii Announces ADS Ratio Change
2025-01-11 05:30
5014
Sino Land Included in Dow Jones Sustainability World Index
2025-01-10 22:01
5005
